Table 1 Number and percentage of articles (95% confidence interval for percentage) published in subscription or open access journals in 2016–2017 satisfying individual items on the CONSORT-A checklist
Item | Subscription journals (n = 149) | OA journals (n = 119) | P value (χ2 test) |
|---|---|---|---|
1. Title | 86 (58%; 49–66%) | 95 (80%; 72–87%) | 0.001 |
2. Trial design | 141 (95%; 89–97%) | 110 (92%; 86–96%) | 0.465 |
Methods | |||
3. Participants | 149 (100%; 97–100%) | 113 (95%; 89–98%) | 0.006 |
4. Interventions | 149 (100%; 97–100%) | 115 (97%; 91–99%) | 0.024 |
5. Objective | 132 (89%; 82–93%) | 115 (97%; 91–99%) | 0.015 |
6. Outcome | 146 (98%; 94–99%) | 111 (93%; 87–97%) | 0.054 |
7. Randomization | 46 (31%; 24–39%) | 46 (39%; 30–48%) | 0.183 |
8. Blinding (masking) | 130 (87%; 81–92%) | 97 (82%; 73–88%) | 0.196 |
Results | |||
9. Number randomized | 87 (58%; 50–66%) | 53 (45%; 36–54%) | 0.024 |
10. Recruitment | 149 (100%; 97–100%) | 117 (98%; 93–100%) | 0.113 |
11. Number analyzed | 71 (48%; 39–56%) | 29 (24%; 17–33%) | 0.001 |
12. Outcome | 64 (43%; 35–5%) | 15 (13%; 7–20%) | < 0.001 |
13. Harms | 114 (77%; 69–83%) | 33 (28%; 20–37%) | < 0.001 |
14. Conclusions | 149 (100%; 97–100%) | 116 (97%; 92–99%) | 0.052 |
15. Trial registration | 149 (100%; 97–100%) | 100 (84%; 76–90%) | < 0.001 |
16. Funding | 112 (75%; 68–81%) | 2 (2%; 0–7%) | < 0.001 |